Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients

SIMPLE SUMMARY: Sarcomas have few effective treatment options due to the rarity and diversity and have a high risk of recurrence and metastasis. Therefore, the development of new therapeutics that can meet their medical needs is required. Our adoptive immunotherapy strategy using T cells to express...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiwara, Kento, Sasawatari, Shigemi, Nakai, Sho, Imaeda, Keisuke, Nagai, Seina, Matsuno, Yoshihiro, Hatanaka, Kanako, Hatanaka, Yutaka, Takenaka, Satoshi, Okada, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598286/
https://www.ncbi.nlm.nih.gov/pubmed/32977646
http://dx.doi.org/10.3390/cancers12102735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598286/
https://www.ncbi.nlm.nih.gov/pubmed/32977646
http://dx.doi.org/10.3390/cancers12102735

Ejemplares similares